The company reported that revenue was up by 34.4%, totaling $570.8 million, with good performance in its divisions. Bruker Scientific Instruments' revenue was up year over year by 34.9% to $517.1 million, and Bruker Energy and Supercon Technologies was up 26.3% to $56.6 million.

The results reflect strong demand for Bruker products and a strong recovery compared to the same period in 2020, the company said.

Bruker also reported an increase in operating income under generally accepted accounting principles (GAAP), with $85.6 million reported in the second quarter of 2021 compared with $37.9 million in 2020. The company reported a diluted GAAP earnings per share of 38¢ for the second quarter (compared with 16¢ in 2020) and a non-GAAP diluted earnings per share of 44¢ compared with 21¢ in the same period of 2020.

Based on performance so far this year, the company raised its guidance for revenue, operating margins, and non-GAAP earnings per share in 2021.

Bruker launches new tools to improve 4D-metabolomics, lipidomics workflows
Bruker has launched several products to enhance the accuracy of 4D-metabolomics and lipidomics workflows, including a new ion source for its trapped ion...

Bruker expands timsTOF product line
Bruker has added two new instruments to its trapped ion mobility spectrometry time-of-flight (timsTOF) product suite, including the second-generation...

Bruker revenues edge higher in Q4
Growth in Bruker's Scientific Instruments business segment and favorable currency effects helped the company to achieve a 4.6% increase in revenue in...

Bruker launches Vutara superresolution microscope
Bruker has announced the launch of the Vutara VXL superresolution fluorescence microscope for use in nanoscale biomedical imaging.

Bruker supports COVID19-NMR Consortium
Bruker is highlighting its support of a global project called COVID19-NMR that will investigate the structure, dynamics, function, and binding of SARS-CoV-2...